Gulsen Kama - Sep 18, 2023 Form 4 Insider Report for Bionano Genomics, Inc. (BNGO)

Signature
/s/ Jonathan V. Dixon, Attorney-in-Fact
Stock symbol
BNGO
Transactions as of
Sep 18, 2023
Transactions value $
$0
Form type
4
Date filed
9/20/2023, 05:21 PM
Previous filing
Sep 20, 2023
Next filing
Jun 5, 2024

Derivative Securities (e.g., puts, calls, warrants, options, convertible securities)

Type Sym Class Transaction Value $ Shares Change % * Price $ Shares After Date Underlying Class Amount Exercise Price Ownership Footnotes
transaction BNGO Stock Option (Right to Buy) Award $0 +106K $0.00 106K Sep 18, 2023 Common Stock 106K $3.00 Direct F1
* An asterisk sign (*) next to the price indicates that the price is likely invalid.

Explanation of Responses:

Id Content
F1 25% of the shares subject to the option shall vest and become exercisable on September 11, 2024, and the remaining shares shall vest in a series of 36 successive equal monthly installments measured from September 11, 2024, subject to Reporting Person's Continuous Service (as defined in the Company's 2020 Inducement Plan, as amended) through each such applicable vesting date and the terms of the Company's 2020 Inducement Plan, as amended.